Novartis eyes $5bn The Medicines Company acquisition - repor...

Novartis is leading a group of companies that are considering buying US pharma The Medicines Company searching for a deal that could expand its pipeline of cardiac medicines, according to p

Novartis’ Mayzent, Roche’s Polivy head latest crop of CHMP a...

Novartis’ Cosentyx didn’t EXCEED Humira in psoriatic arthrit...

FDA slaps hold on Zolgensma trials as animal data raises saf...

Novartis takes $80M punt on early-stage NASH drug from Plian...

Zolgensma hits the ground running, says Novartis